Antibiotic Concentration (Cefuroxime) in Plasma
This test measures the amount of the antibiotic cefuroxime in your blood plasma. It helps doctors determine whether your dose is effective and monitor your response to treatment.
["This test helps ensure your antibiotic is working properly and adjusts your treatment if needed."]
Key facts at a glance
- LOINC
- 147-9
- Short code
- CEFSBT
- Synonyms
- Cefuroxime Parenter Titr SBT
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube (no anticoagulant); sterile cryovials recommended for frozen transport
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Serum bactericidal titer (Schlichter test) - microdilution or macrodilution broth methodology using serial two-fold dilutions of patient serum incubated with a standardized bacterial inoculum
- CPT
- 87197
- SNOMED
- 104281000
- Specimen volume
- 2-5 mL of serum (minimum 1 mL)
- Stability
- Serum should be frozen at -70°C or colder for prolonged storage; refrigerated (2-8°C) stability is limited to 24-48 hours; ideally processed immediately or stored frozen until testing
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
Why This Test Is Done
Your healthcare provider may order this test if you’re receiving cefuroxime therapy, particularly for infections that require higher doses or prolonged treatment. It helps optimize your medication to avoid resistance or side effects while targeting the infection.
What to Expect Before the Test
No special preparation is needed. You may have a small needle inserted into your vein (venipuncture) or a blood sample drawn from your arm. If you’re on intravenous cefuroxime, your plasma level may be checked during or shortly after infusion.
What the Test Results Mean
Results are typically reported as a concentration value (e.g., micrograms per milliliter). Your doctor will compare this to your treatment plan to guide dosing adjustments.
Possible Side Effects or Considerations
Cefuroxime is generally well-tolerated, but high plasma levels may cause mild side effects like nausea or allergic reactions. If you experience severe reactions (e.g., rash, difficulty breathing), seek medical attention immediately.
Reference range
Titer >=1:8 generally considered indicative of adequate antibacterial activity for most serious infections; Titer >=1:16 recommended for endocarditis and other deep-seated/life-threatening infections; specific interpretive criteria depend on infection site, pathogen, and host factorsN/A
No special patient preparation required. Specimen should be collected at steady-state pharmacokinetic conditions (typically after at least 3-5 doses). Trough and peak levels (collected 30 minutes before next dose and 30-60 minutes after dose completion, respectively) are commonly obtained to guide dosing.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
Cefuroxime Plasma Level
Frequently asked questions
How does cefuroxime concentration relate to infection control?
Can this test detect resistance to cefuroxime?
What if my test results are outside the expected range?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy